Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization

Title
Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization
Authors
Keywords
Prosthetic replacement of ocular surface ecosystem (PROSE), Scleral lens, Corneal neovascularization, Vascular endothelial growth factor (VEGF), Bevacizumab, Ocular surface disease
Journal
Ocular Surface
Volume 17, Issue 1, Pages 134-141
Publisher
Elsevier BV
Online
2018-11-20
DOI
10.1016/j.jtos.2018.11.008

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started